Searched for
COST PLUS DRUG COMPANY
Mark Cuban says AI hack agents are like cockroaches, but can be controlledCuban, famous for his role on business reality show "Shark Tank" and his involvement in the Dallas Mavericks NBA team, ventured into health...- States urged to enforce ban on reuse of single-use medical devicesThe Directorate General of Health Services has issued a directive to prohibit the reuse of single-use medical devices. Violations by some p...
- Viral video allegedly shows child consuming drugs in Punjab's Kapurthala, political leaders raise alarmA viral video allegedly showing a child consuming drugs in Kapurthala, Punjab, has prompted criticism from Shiromani Akali Dal MP Harsimrat...
- Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...
- Jubilant Pharmova eyes $150 million through rupee debt sale, bankers sayJubilant Pharmova plans to raise around Rs 14 billion ($150 million) through a three-year rupee bond offering to fund capital expenditure a...
- Hospitals overcharge patients upto 700% on medicines while India makes some of the world’s lowest priced drugs: Centre admits to SCGovt has told Supreme Court that hospitals overcharging patients for medicines and medical consumables is a malpractice. Its affidavit cite...
- OnePlus Diwali Sale 2026: Check discounts on OnePlus 15, Nord CE6 lite and N6x, effective prices of smartphones, tablets and earbuds, bank offers and EMI dealsDuring the vibrant festive season, OnePlus is rolling out enticing discounts on an array of smartphones, tablets, and audio devices. The Di...
- AAP chief Aravind Kejriwal questions HM Amit Shah over drug menace in BJP-ruled statesArvind Kejriwal criticised Amit Shah for the ongoing drug issues in BJP-ruled states like Bihar and Gujarat. Shah had expressed his sadness...
- Ozempic wave boosts US cobblers and tailors as Americans tighten their beltsConsumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
- Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
- Dr Reddy's gets DCGI nod for Zytorvi in advanced esophageal cancerDr Reddy's Laboratories has received approval for Zytorvi, an immunotherapy targeting advanced esophageal squamous cell carcinoma. This new...
- US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatmentHibsago, GSK's new hepatitis B treatment, recently secured approval from the US FDA, allowing patients to better manage their condition aft...
- Amit Shah says Punjab drug trade more harrowing than official reports suggestUnion Home Minister Amit Shah recently visited Punjab, where he met families impacted by drug abuse. He specifically visited Gurdaspur, San...
- As weight-loss drug users turn to dietary supplements, doctors, regulators raise flagsThe growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to...
- GLP-1 prices drop at Mochi Health, starting at $60 but what will patients actually pay?Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...
- Rising AI costs force companies to cap spending, says Goldman SachsIn ‘Connecting the Dots’ report, Goldman Sachs highlights how businesses are controlling AI bills by setting usage limits, removing tools t...
- NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
Load More
